Evolving Care for patients with EGID: Read about how we are changing the outcome!
www.cincinnatichildrens.org/professional...
Researchers have found positive results in mouse models of severe #allergy when treating them with an allergen-specific #mRNA lipid nanoparticle therapeutic platform technology.
Healio spoke with Dr. Marc E. Rothenberg to learn more.
www.healio.com/news/allergy...
Penicillin Allergy Decision & Mobile Empowerment (PADME)-Ideation and design of a novel delabeling program for children
pubmed.ncbi.nlm.nih.gov/41443336/
Turning our lights Pink for National Eosinophil Awareness Week! #NEAW
Penicillin Allergy Decision & Mobile Empowerment (PADME)-Ideation and design of a novel delabeling program for children
pubmed.ncbi.nlm.nih.gov
Discover how Cincinnati Children’s is improving eosinophilic gastrointestinal disorder (EGID) care with FDA-approved drugs, transnasal endoscopy, and advanced diagnostic scoring systems.
Researchers have found positive results in mouse models of severe allergy when treating them with an allergen-specific mRNA lipid nanoparticle therapeutic platform technology, according to a press rel...
